Double‐bright (CD56bright/CD16bright) natural killer cell adoptive immunotherapy for SARS‐CoV‐2
Journal article published in 2020 by
Lúcia Silla 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 